ES2176156T3 - Derivados del benzo-(3,4-ciclobutano-1,2c)-pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Derivados del benzo-(3,4-ciclobutano-1,2c)-pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2176156T3
ES2176156T3 ES00400812T ES00400812T ES2176156T3 ES 2176156 T3 ES2176156 T3 ES 2176156T3 ES 00400812 T ES00400812 T ES 00400812T ES 00400812 T ES00400812 T ES 00400812T ES 2176156 T3 ES2176156 T3 ES 2176156T3
Authority
ES
Spain
Prior art keywords
branched
linear
ciclobutan
pirrol
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00400812T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Aimee Dessinges
Mark Millan
Jean-Michel Rivet
Anne Dekeyne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Application granted granted Critical
Publication of ES2176156T3 publication Critical patent/ES2176156T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de fórmula (I), con unión de ciclo cis: **fórmula**, en la cual: R1,R2,R3, idénticos o diferentes, independientemente uno del otro representan un grupo seleccionado entre átomo de hidrógeno, halógeno, grupo alquilo (C1-C6) lineal o ramificado, alquenilo (C2-C6) lineal o ramificado, alquinilo (C2-C6), hidroxilo, alcoxilo (C1-C6) lineal o ramificado, cicloalquilo, cicloalquil-alquilo (C1-C6) lineal o ramificado, arilo, aril-alquilo (C1-C2) lineal o ramificado, aril-oxilo, aril-alcoxilo (C1-C6) lineal o ramificado, trihalo-alquilo (C1-C6) lineal o ramificado, ciano, nitro, un grupo de fórmula OSO2CH3, -OSO2CF3, NR6R7, CO2R6 en los cuales R6 y R7, idénticos o diferentes, independientemente el uno del otro, representan un átomo de hidrógeno, un grupo alquilo(C1-C6) lineal o ramificado, alquenilo.
ES00400812T 1999-03-26 2000-03-24 Derivados del benzo-(3,4-ciclobutano-1,2c)-pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2176156T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903811A FR2791345B1 (fr) 1999-03-26 1999-03-26 Nouveaux derives du benzo[3,4]cyclobuta[1,2-c]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2176156T3 true ES2176156T3 (es) 2002-12-01

Family

ID=9543685

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00400812T Expired - Lifetime ES2176156T3 (es) 1999-03-26 2000-03-24 Derivados del benzo-(3,4-ciclobutano-1,2c)-pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (21)

Country Link
US (1) US6153640A (es)
EP (1) EP1038873B1 (es)
JP (1) JP3256788B2 (es)
KR (1) KR100427127B1 (es)
CN (1) CN1166638C (es)
AT (1) ATE216994T1 (es)
AU (1) AU762990B2 (es)
BR (1) BR0001420A (es)
CA (1) CA2301787C (es)
DE (1) DE60000142T2 (es)
DK (1) DK1038873T3 (es)
EA (1) EA003302B1 (es)
ES (1) ES2176156T3 (es)
FR (1) FR2791345B1 (es)
HU (1) HUP0001246A3 (es)
NO (1) NO315513B1 (es)
NZ (1) NZ503588A (es)
PL (1) PL339203A1 (es)
PT (1) PT1038873E (es)
SI (1) SI1038873T1 (es)
ZA (1) ZA200001501B (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK136420B (da) * 1972-09-29 1977-10-10 Sandoz Ag Analogifremgangsmåde til fremstilling af isoindolinforbindelser.
US4171369A (en) * 1972-09-29 1979-10-16 Sandoz Ltd. Hydro-4-phenyl-benz[f]isoindoline compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0170093B1 (en) * 1984-07-25 1990-03-07 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrdes
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5574060A (en) * 1993-08-12 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Selective inhibitors of biogenic amine transporters
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
NO315513B1 (no) 2003-09-15
EA003302B1 (ru) 2003-04-24
JP2000290253A (ja) 2000-10-17
ATE216994T1 (de) 2002-05-15
AU762990B2 (en) 2003-07-10
ZA200001501B (en) 2000-10-24
FR2791345B1 (fr) 2001-05-04
PT1038873E (pt) 2002-09-30
DE60000142D1 (de) 2002-06-06
DK1038873T3 (da) 2002-08-19
BR0001420A (pt) 2000-10-10
HU0001246D0 (en) 2000-06-28
SI1038873T1 (en) 2002-08-31
PL339203A1 (en) 2000-10-09
HK1031380A1 (en) 2001-06-15
CN1274718A (zh) 2000-11-29
EP1038873A2 (fr) 2000-09-27
EP1038873A3 (fr) 2000-10-04
HUP0001246A3 (en) 2002-02-28
NO20001542L (no) 2000-09-27
NZ503588A (en) 2000-12-22
US6153640A (en) 2000-11-28
NO20001542D0 (no) 2000-03-24
KR20010006863A (ko) 2001-01-26
DE60000142T2 (de) 2002-12-12
KR100427127B1 (ko) 2004-04-17
JP3256788B2 (ja) 2002-02-12
HUP0001246A2 (hu) 2001-01-29
AU2257900A (en) 2000-09-28
EA200000260A2 (ru) 2000-12-25
CA2301787A1 (fr) 2000-09-26
CN1166638C (zh) 2004-09-15
FR2791345A1 (fr) 2000-09-29
EP1038873B1 (fr) 2002-05-02
CA2301787C (fr) 2004-11-02

Similar Documents

Publication Publication Date Title
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
AR023497A1 (es) Ent-esteroides en calidad de estrogenos con efecto selectivo, su empleo para el tratamiento de las enfermedades y los estados motivados por una deficienciade estrogenos en la mujer y en el hombre, y las composiciones farmaceuticas que contienen estos ent-esteroides
PY08034070A (es) Derivados de 1, 2, 4, 5-tetrahidro -3-H- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
AR020032A1 (es) Derivados de 1,3 -metil eritromicina.
AR020165A1 (es) Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos
ES2176698T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2065755T3 (es) Derivados de 3-aminopiridacinas activos sobre el sistema nervioso central.
PA8768301A1 (es) Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen
AR039988A1 (es) Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos
CY1106692T1 (el) Παραγωγα του αλοξενοϋλ-κυκλοπροπαν-1-καρβοξυλικου οξεος
AR033957A1 (es) Nuevos compuestos
AR001838A1 (es) Derivados de azacicloal canos utiles para el tratamiento de la obesidad diabetes e hiperglucemia procedimiento para prepararlos composiciones farmacéuticas que los contienen y aplicación de dichos derivados en la preparación de dichas composiciones
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
ES2189747T3 (es) Procedimiento para la preparacion de taxanos a partir de 10-desacetilbacatina iii.
ES2184467T3 (es) Derivados de la piperacina para la inhibicion de la replicacion del virus de la inmunodeficiencia humana.
ES2180524T3 (es) Nuevos derivados de benceno-sulfon-amidas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados
AR046768A1 (es) Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas
ES2176156T3 (es) Derivados del benzo-(3,4-ciclobutano-1,2c)-pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO5160255A1 (es) DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN
CO5550429A2 (es) Formulaciones de lactona y metodos de uso
CY1105972T1 (el) ΝΕΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ [1,4] ΒΕΝΖΟΔΙΟΞΙΝΟ [2,3-e] ΙΣΟΪΝΔΟΛΙΟΥ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΑΥΤΩΝ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠEPΙΕΧΟΥΝ